Crossref
Integrating Dermocosmetic Therapy for Acne: Addressing Severity Levels in Real-Life Experiences
Journal of Drugs in Dermatology · 01.01.2025 · 24 (1) · 88-94
DOI: 10.36849/jdd.8877 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.12.2024. Verfasst von Magda Belmontesi. Hauptthemen laut MEDLINE: Acne Vulgaris, Severity of Illness Index, Patient Satisfaction. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Acne VulgarisSeverity of Illness IndexPatient SatisfactionHumansFemaleMaleAdolescentAdultYoung AdultDermatologic AgentsSurveys and QuestionnairesTreatment OutcomePatient ComplianceSkin Cream
Substanzen
Dermatologic Agents
Zitieren
APA
Belmontesi, M. (2025). Integrating Dermocosmetic Therapy for Acne: Addressing Severity Levels in Real-Life Experiences. Journal of Drugs in Dermatology, 24(1), 88-94. https://doi.org/10.36849/jdd.8877
Vancouver
Belmontesi M. Integrating Dermocosmetic Therapy for Acne: Addressing Severity Levels in Real-Life Experiences. Journal of Drugs in Dermatology. 2025;24(1):88-94. doi:10.36849/jdd.8877
BibTeX
@article{Belmontesi2025,
author = {Belmontesi, Magda},
title = {Integrating Dermocosmetic Therapy for Acne: Addressing Severity Levels in Real-Life Experiences},
journal = {Journal of Drugs in Dermatology},
year = {2025},
volume = {24},
number = {1},
pages = {88--94},
doi = {10.36849/jdd.8877}
}
EUVIMED